BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15973556)

  • 1. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
    [No Abstract]   [Full Text] [Related]  

  • 2. American society of clinical oncology--41st annual meeting.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):525-7. PubMed ID: 15973553
    [No Abstract]   [Full Text] [Related]  

  • 3. American Society of Clinical Oncology--41st annual meeting. Drug highlights I.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):531-3. PubMed ID: 15973555
    [No Abstract]   [Full Text] [Related]  

  • 4. American society of clinical oncology--41st annual meeting. Immunology.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
    [No Abstract]   [Full Text] [Related]  

  • 5. [ASCO-Update 2005--Highlights of the 41st Meeting of the American Society of Clinical Oncology/ASCO 2005].
    Höhler T; Heike M; Lutz MP; Graeven U; Seufferlein T;
    Z Gastroenterol; 2005 Nov; 43(11):1253-9. PubMed ID: 16267711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights from the 41st Annual Meeting of the American Society of Clinical Oncology, May 2005, and the 2005 American Society of Clinical Oncology Prostate Cancer Symposium, February 2005, Orlando, Florida.
    Reddy GK; Tyagi P
    Clin Prostate Cancer; 2005 Jun; 4(1):7-14. PubMed ID: 15992456
    [No Abstract]   [Full Text] [Related]  

  • 7. Digestive Disease Week 2005. Drug highlights I.
    De La Rue SA
    IDrugs; 2005 Jul; 8(7):537-8. PubMed ID: 15973557
    [No Abstract]   [Full Text] [Related]  

  • 8. The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005.
    Montemurro F; Valabrega G; Garetto L; Aliberti S; Grignani G; Ortega C; Leone F; Ponzone R; Aglietta M
    Expert Opin Pharmacother; 2005 Dec; 6(16):2907-21. PubMed ID: 16318441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency.
    Cunanan KM; Gonen M; Shen R; Hyman DM; Riely GJ; Begg CB; Iasonos A
    J Clin Oncol; 2017 Jan; 35(3):271-273. PubMed ID: 27893325
    [No Abstract]   [Full Text] [Related]  

  • 10. Epothilone D (Kosan/Roche).
    Kolman A
    Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digestive Disease Week 2005. Drug highlights II.
    De La Rue SA
    IDrugs; 2005 Jul; 8(7):539-41. PubMed ID: 15973558
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights of the American Society of Clinical Oncology annual meeting 2005. 13-17 May, 2005, Florida, USA.
    Burstein HJ
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):581-3. PubMed ID: 16111459
    [No Abstract]   [Full Text] [Related]  

  • 13. Japanese Pharmacological Society--77th Annual Meeting. Part II. 8-10 March 2004, Osaka, Japan.
    Robins P
    IDrugs; 2004 Apr; 7(4):298-300. PubMed ID: 15057629
    [No Abstract]   [Full Text] [Related]  

  • 14. 39th annual meeting of the American Society of Clinical Oncology.
    Klem J
    Clin Lymphoma; 2003 Sep; 4(2):73-8. PubMed ID: 14556676
    [No Abstract]   [Full Text] [Related]  

  • 15. American Society of Clinical Oncology 41st annual meeting.
    Dillman RO
    Expert Opin Biol Ther; 2005 Aug; 5(8):1117-27. PubMed ID: 16050788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006].
    Reinacher-Schick A; Arnold D; Lordick F; Möhler M; Lutz MP; Seufferlein T;
    Z Gastroenterol; 2006 Oct; 44(10):1065-72. PubMed ID: 17063436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OSI-461 (OSI).
    Galmarini CM
    Curr Opin Investig Drugs; 2004 Jun; 5(6):648-56. PubMed ID: 15242254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drugs take centre stage at US cancer meeting.
    McCarthy M
    Lancet; 2001 May; 357(9268):1593. PubMed ID: 11377652
    [No Abstract]   [Full Text] [Related]  

  • 19. MS-209 Schering.
    Robert J
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1340-7. PubMed ID: 15648956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does a drug get to phase III trials?
    Reynolds T
    J Natl Cancer Inst; 2000 Oct; 92(19):1555. PubMed ID: 11018084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.